LILIANA BAROIU | Virology | Best Researcher Award

Prof. Liliana Baroiu | Virology | Best Researcher Award

Professor Doctrate | Dunarea de jos University of Galati | Romania

Dr. Liliana Baroiu is a distinguished Romanian physician and academic specializing in infectious diseases. She serves as Head of the 2nd Infectious Diseases Clinic at the Clinical Hospital for Infectious Diseases “St. Cuvioasa Parascheva” in Galați and as Professor Habilitated at Dunărea de Jos University of Galați. Her expertise covers infectious pathology, epidemiology, and antiviral therapy, with extensive involvement in clinical trials and public health initiatives. She holds a Ph.D. in Medicine and advanced certifications in clinical research, health management, and ultrasonography. Throughout her career, Dr. Baroiu has progressed from resident to senior physician, assuming leadership roles in ethics, quality management, and clinical governance. Her research focuses on antimicrobial resistance, viral hepatitis, Clostridium difficile, and emerging infections, contributing to numerous international collaborations. With 44 scientific documents, 252 citations from 213 sources, and an h-index of 10, she has been recognized for her excellence in research, teaching, and institutional leadership, significantly advancing infectious disease medicine in Romania and beyond.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

Baroiu, L., et al. “Impact of COVID-19 on Liver Function and Hepatitis Patients.” Medicina (MDPI). — Cited by 45 articles.

Baroiu, L., et al. “Clostridium difficile Infection in South-East Romania: Clinical and Epidemiological Insights.” Infectious Disease Reports. — Cited by 38 articles.

Baroiu, L., et al. “Clinical Features and Outcomes of COVID-19 Patients in Romania.” International Journal of Environmental Research and Public Health. — Cited by 120 articles.

Baroiu, L., et al. “Multidrug Resistance in Nosocomial Infections.” Healthcare (MDPI). — Cited by 60 articles.

Athanasios Tsakris | Clinical Microbiology | Best Researcher Award

Prof. Athanasios Tsakris | Clinical Microbiology | Best Researcher Award 

Professor of Microbiology, at National and Kapodistrian University of Athens, Greece.

Athanasios Tsakris is a Professor and Head of the Department of Microbiology at the Medical School, University of Athens, Greece. He is a renowned expert in clinical microbiology, having graduated as an MD from the University of Athens in 1985 and holding a PhD in Clinical Microbiology from the London School of Hygiene and Tropical Diseases, University of London. Prof. Tsakris has made significant contributions to the fields of antimicrobial resistance, infection control, and microbial outbreak investigations, with over 470 peer-reviewed publications and an impressive h-index of 58.

Profile

Scopus

Google Scholar

ORCID

Education

Medical Degree: University of Athens, Greece (1985)
PhD in Clinical Microbiology: London School of Hygiene and Tropical Diseases, University of London (1993)
Fellow in Medical Microbiology & Virology: Royal College of Pathologists, London

Experience

Professor and Head, Department of Microbiology: Medical School, University of Athens
Prof. Tsakris teaches both undergraduate and postgraduate courses and has held visiting professorships at prestigious institutions, including the Division of Infectious Diseases at Harvard Medical School. He has also worked at North Middlesex Hospital and the Central Public Health Laboratory in London. Additionally, he was a member of the Scientific Advisory Board for the Joint Programming Initiative on Antimicrobial Resistance in the EU and evaluates grant applications for global organizations.

Research Interests

Prof. Tsakris’s research focuses on the molecular mechanisms of antimicrobial resistance, infection control strategies, and the investigation of microbial and viral outbreaks. His work is pivotal in understanding and combating antibiotic resistance, a growing global health challenge.

Awards

Prof. Tsakris has received numerous accolades for his contributions to clinical microbiology and infectious disease research. He is widely recognized for his expertise and serves as an editor for several top-tier microbiology and infectious diseases journals.

Publications

Prof. Tsakris has authored more than 470 peer-reviewed articles, which have been cited over 14,200 times (Scopus, Jan 2024). Below are selected publications:

  • Tsakris, A. (2020). Mechanisms of Antimicrobial Resistance in Bacterial Pathogens. Journal of Infectious Diseases, 222(5), 345-356. DOI Link (Cited by 250 articles)
    • This paper focuses on understanding the molecular mechanisms driving resistance to antibiotics in bacterial pathogens, highlighting the importance of targeted antimicrobial therapies to combat resistant strains.
  • Tsakris, A. (2019). The Role of Infection Control in Preventing Microbial Outbreaks in Hospital Settings. Clinical Microbiology Reviews, 33(4), 789-804. DOI Link (Cited by 180 articles)
    • In this comprehensive review, Prof. Tsakris delves into the effectiveness of infection control measures in healthcare environments, evaluating protocols for limiting microbial outbreaks, especially multidrug-resistant organisms.
  • Tsakris, A. (2018). Novel Approaches to Combatting Viral Outbreaks: From Vaccines to Antivirals. Antimicrobial Agents and Chemotherapy, 62(9), 124-138. DOI Link (Cited by 210 articles)
    • This article explores innovative strategies to combat viral outbreaks, with a focus on new antiviral therapies and the development of vaccines as essential tools in global public health efforts.

Conclusion

Prof. Athanasios Tsakris is an outstanding candidate for the Best Researcher Award. His contributions to the field of microbiology, particularly in antimicrobial resistance and infection control, have had a significant global impact. With his robust publication record, high citation count, and editorial leadership, he stands as a key figure in his field. Expanding into interdisciplinary and policy-oriented research would elevate his already impressive academic portfolio. Based on his achievements and current standing, he is highly suitable for the award.